GRFS Grifols, S.A.
Healthcare$8.01+0.38%ClosedMarket Cap: $6.78B
As of 2026-05-26
Valuation
P/E (TTM)
17.32
PEG
0.11
P/B
1.21
P/S
0.89
EV/EBITDA
10.87
DCF Value
$21.42
FCF Yield
11.4%
Div Yield
1.5%
Margins & Returns
Gross Margin
37.7%
Operating Margin
16.9%
Net Margin
5.6%
ROE
7.9%
ROA
2.1%
ROIC
5.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.73B | 36.5% | $253.1M | $74.2M | $— | — |
| Q4 null | $1.96B | 34.7% | $272.2M | $97.3M | $— | — |
| FY null | $7.23B | 35.7% | $1.19B | $386.1M | $— | $0.14 |
| Q3 null | $1.87B | 40.3% | $383.3M | $127.0M | $— | $0.14 |
| Q2 null | $1.89B | 39.3% | $348.9M | $117.1M | $— | — |
| Q1 null | $1.79B | 39.5% | $268.9M | $59.7M | $— | — |
| Q4 null | $1.98B | 38.8% | $371.9M | $69.0M | $— | — |
| FY null | $7.21B | 38.7% | $1.19B | $156.9M | $— | — |
| Q3 null | $1.79B | 40.5% | $317.0M | $51.7M | $— | — |
| Q2 null | $1.82B | 36.9% | $299.3M | $14.8M | $— | — |
| Q1 null | $1.63B | 39.9% | $203.8M | $21.4M | $— | — |
| Q4 2023 | $1.77B | 39.0% | $254.8M | $56.0M | $0.08 | — |